The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Nuclear Factor κB Is a Molecular Target for Sulforaphane-mediated Anti-inflammatory Mechanisms
Open accessAbstract
Sulforaphane (SFN), an aliphatic isothiocyanate, is a known cancer chemopreventive agent. Aiming to investigate anti-inflammatory mechanisms of SFN, we here report a potent decrease in lipopolysaccharide (LPS)-induced secretion of pro-inflammatory and pro-carcinogenic signaling factors in cultured Raw 264.7 macrophages after SFN treatment, i.e. NO, prostaglandin E(2), and tumor necrosis factor alpha. SFN did not directly interact with NO, nor did it inhibit inducible nitric-oxide synthase enzymatic activity. Western blot analyses revealed time- and dose-dependent reduction of LPS-induced inducible nitric-oxide synthase as well as Cox-2 protein expression, which was suppressed at the transcriptional level. To reveal the target of SFN beyond its anti-inflammatory action, we performed electrophoretic mobility shift assay analyses of transcription factor-DNA binding. Consequently, nuclear factor kappa B (NF-kappa B), a pivotal transcription factor in LPS-stimulated pro-inflammatory response, was identified as the key mediator. SFN selectively reduced DNA binding of NF-kappa B without interfering with LPS-induced degradation of the inhibitor of NF-kappa B nor with nuclear translocation of NF-kappa B. Because SFN can interact with thiol groups by dithiocarbamate formation, it may impair the redox-sensitive DNA binding and transactivation of NF-kappa B. Sulforaphane could either directly inactivate NF-kappa B subunits by binding to essential Cys residues or interact with glutathione or other redox regulators like thioredoxin and Ref-1 relevant for NF-kappa B function. Our data provide novel evidence that anti-inflammatory mechanisms contribute to sulforaphane-mediated cancer chemoprevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Ding, A. H., Nathan, C. F., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,826
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Xie, Q. W., Whisnant, R., & Nathan, C. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1779 · Cited by 1,118
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9730 · Cited by 1,064
Ohshima, H., & Bartsch, H. (1994) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(94)90245-3 · Cited by 1,055
Self-citationMatthews, J. R., Wakasugi, N., virelizier, J.-L., Yodoi, J., & Hay, R. T. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.15.3821 · Cited by 831
Zhang, Y., Kensler, T. W., Cho, C. G., Posner, G. H., & Talalay, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3147 · Cited by 745
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Xanthoudakis, S., & Curran, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05097.x · Cited by 708
Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.
Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q. W., & Nathan, C. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.605 · Cited by 655
Gamet‐Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M.-A., Chevolleau, S., Gasc, N., Tulliez, J. E., & Tercé, F. (2000) · PubMed · Cited by 618
Distinct Roles of Thioredoxin in the Cytoplasm and in the Nucleus
Hirota, K., Murata, M., Sachi, Y., Nakamura, H., Takeuchi, J., Mori, K., & Yodoi, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27891 · Cited by 611
Ben-Av, P., Crofford, L. J., Wilder, R. L., & Hla, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00956-a · Cited by 566
Lin, Y., & Lin, J. (1997) · PubMed · Cited by 539
Evans, A. R., Limp-Foster, M., & Kelley, M. R. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00046-x · Cited by 532
Tsai, S., Lin‐Shiau, S., & Lin, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702357 · Cited by 511
Holmes-McNary, M. Q., & Baldwin, A. S. (2000) · PubMed · doi:10.17615/wdcc-wb89 · Cited by 498
Antioxidant Functions of Sulforaphane: a Potent Inducer of Phase II Detoxication Enzymes
Fahey, J. W., & Talalay, P. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00082-4 · Cited by 482
Lin, Y.-L., & Lin, J.-K. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.465 · Cited by 463
Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons
Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., & Beal, M. F. (1996) · Nature Medicine · doi:10.1038/nm0996-1017 · Cited by 422
Anderson, M. T., Staal, F. J., Gitler, C., Herzenberg, L. A., & Herzenberg, L. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11527 · Cited by 401
Chung, F.-L. (2000) · Carcinogenesis · doi:10.1093/carcin/21.12.2287 · Cited by 350
Peptide growth factors and inflammation, tissue repair, and cancer.
Sporn, M. B., & Roberts, A. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112580 · Cited by 346
Cellular thiols and redox-regulated signal transduction
(2001) · Current Topics in Cellular Regulation · doi:10.1016/s0070-2137(01)80001-7 · Cited by 343
Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages
Wadleigh, D. J., Reddy, S. T., Kopp, E., Ghosh, S., & Herschman, H. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6259 · Cited by 339
Hooper, D. C., Bagasra, O., Marini, J. C., Zborek, A., Ohnishi, S. T., Kean, R., Champion, J. M., Sarker, A. B., Bobroski, L., Farber, J. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2528 · Cited by 334
Suh, N., Honda, T., Finlay, H. J., Barchowsky, A., Williams, C. R., Benoit, N. E., Xie, Q. W., Nathan, C., Gribble, G. W., & Sporn, M. B. (1998) · PubMed · Cited by 326
Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., & Kong, A.-N. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27545 · Cited by 281
High-performance affinity beads for identifying drug receptors
Shimizu, N., Sugimoto, K., Tang, J., Nishi, T., Sato, I., Hiramoto, M., Aizawa, S., Hatakeyama, M., Ohba, R., Hatori, H., et al. (2000) · Nature Biotechnology · doi:10.1038/78496 · Cited by 250
Zhang, Y. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.175 · Cited by 234
IL-6-regulated transcription factors
Akira, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00063-0 · Cited by 233
Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention
Subbaramaiah, K., Zakim, D., Weksler, B. B., & Dannenberg, A. J. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44170 · Cited by 222
Hirota, K., Matsui, M., Murata, M., Takashima, Y., Cheng, F. S., Itoh, T., Fukuda, K., & Junji, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3106 · Cited by 203
1-Chloro-2,4-dinitrobenzene Is an Irreversible Inhibitor of Human Thioredoxin Reductase
Arnér, E. S. J., Björnstedt, M., & Holmgren, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3479 · Cited by 187
Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.
Subbaramaiah, K., Michaluart, P., Sporn, M. B., & Dannenberg, A. J. (2000) · PubMed · Cited by 174
Steer, J. H., Kroeger, K. M., Abraham, L. J., & Joyce, D. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906304199 · Cited by 155
Mitomo, K., Kohzo, N., Kotaro, F., Xiangao, S., Shuji, S., & Yamamoto, K.-I. (1994) · Gene · doi:10.1016/0378-1119(94)90005-1 · Cited by 150
Takahashi, M., Fukuda, K., Ohata, T., Sügimura, T., & Wakabayashi, K. (1997) · PubMed · Cited by 134
Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage
Graziewicz, M. A., Wink, D. A., & Laval, F. (1996) · Carcinogenesis · doi:10.1093/carcin/17.11.2501 · Cited by 126
Chen, C., Wang, J. K. T., & Lin, S. (1998) · PubMed · Cited by 121
Chen, C.-C., Wang, J.-K., & Lin, S.-B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6206 · Cited by 106
Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genes
Xia, C., Cheshire, J. K., Patel, H. K., & Woo, P. M. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00083-6 · Cited by 102
Schmidt, T. J., Lyß, G., Pahl, H. L., & Merfort, I. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00234-5 · Cited by 87
Nuclear Targeted Suppression of NF-κB Activity by the Novel Quinone Derivative E3330
Hiramoto, M., Shimizu, N., Sugimoto, K., Tang, J., Kawakami, Y., Ito, M., Aizawa, S., Tanaka, H., Makino, I., & Handa, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.810 · Cited by 87
Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330.
Hiramoto, M., Shimizu, N., Sugimoto, K., et al. (1998) · PubMed · Cited by 78
Yuan, C. J., Mandal, A. K., Zhang, Z., & Mukherjee, A. B. (2000) · PubMed · Cited by 75
Buchmüller-Rouiller, Y., Corradin, S. B., Smith, J., Schneider, P., Ransijn, A., Jongeneel, C. V., & Mauël, J. (1995) · Cellular Immunology · doi:10.1006/cimm.1995.1144 · Cited by 73
Liu, G., Frank, N., Bartsch, H., & Lin, J. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199808)22:4<235::aid-mc5>3.0.co;2-i · Cited by 61
Self-citationA Novel Lipopolysaccharide-response Element Contributes to Induction of Nitric Oxide Synthase
Xie, Q. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14867 · Cited by 58
Chen, C., Wang, J.-K., & Chen, W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00697-2 · Cited by 21
Research works printed but not linked: 18
- Sporn, 1979, Fed. Proc., 38, 2528
- Gerhäuser, 1997, Cancer Res., 57, 272
- Lee, 1999, Anticancer Res., 19, 35
- Gamet-Payrastre, 2000, Cancer Res., 60, 1426
- Takahashi, 1997, Cancer Res., 57, 1233
- Sheng, 1998, Cancer Res., 58, 362
- Fujiki, 1994, J. Biochem. (Tokyo), 115, 1, 10.1093/oxfordjournals.jbchem.a124282 · doi:10.1093/oxfordjournals.jbchem.a124282
- Fujiki, 2000, Cancer Detect. Prev., 24, 91
- Kim, 1986, J. Org. Chem., 51, 2613, 10.1021/jo00363a046 · doi:10.1021/jo00363a046
- Schmid, 1948, Helv. Chim. Acta, 31, 1497, 10.1002/hlca.19480310608 · doi:10.1002/hlca.19480310608
- Zheng, 1991, Biochem. Biophys. Res. Commun., 175, 48, 10.1016/S0006-291X(05)81198-2 · doi:10.1016/s0006-291x(05)81198-2
- Suh, 1998, Cancer Res., 58, 717
- Yuan, 2000, Cancer Res., 60, 1084
- Subbaramaiah, 2000, Cancer Res., 60, 2399
- Holmes-McNary, 2000, Cancer Res., 60, 3477
- Zhang, 2000, Carcinogenesis, 21, 1175, 10.1093/carcin/21.6.1175 · doi:10.1093/carcin/21.6.1175 · Paper page
- Sen, 2000, Curr. Top. Cell Regul., 36, 1
- Gerhäuser, 1999, Proc. Am. Assoc. Cancer Res., 40, 359
Cited by
Transcriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,192
Nrf2 signaling pathway: pivotal roles in inflammation
Ahmed, S. M. U., Luo, L., Namani, A., Wang, X. J., & Tang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.005 · Cited by 1,794
An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020) · Molecules · doi:10.3390/molecules25225474 · Cited by 1,388
Cysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery
Paulsen, C. E., & Carroll, K. S. (2013) · Chemical Reviews · doi:10.1021/cr300163e · Cited by 1,278
NRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067
Metadata
- Authors
- Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., & Gerhäuser, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-08
- Volume
- 276
- Issue
- 34
- Pages
- 32008-32015
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1991201692
- Cited by
- 632
- References
- 63
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7016 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.